14 | Prediction censored data | TopicSem | ||
17 | Combination chemotherapy in advanced gastric cancer | SysBiol |
08 | skin classification | xMutant | ||
20 | Synthetic Lethality-based Identifcation of Targets for Anticancer Drugs in the Human Signaling Network | J.Club |
13 | TP53 Paclitaxel SC Network is Prognostic Factor on Urogenital Cancers | SysBiol | ||
27 | NGS Sequencing to Detect Genetic Biomarker of Busulfan Induced Hepatotoxicity | TopicSem |
12 | NGS biomarker for busulfan ADR | SysBiol | ||
12 | NGS biomarker for busulfan ADR | SysBiol | ||
19 | Bipartite approach for Metalab DRUG-ADR network | TopicSem |
09 | Inference of Digenic Disruption Networks for Synthetic Cytotoxicity | TopicSem |
07 | Non-linear model to predict cytotoxic drug response | SysBiol | ||
20 | Microarray data analysis of multi-center breast cancer patients with distant metastasis | TopicSem | ||
21 | Inference of candidate Synthetic Cytotoxic Drug (Pyrimethamine, Paclitaxel) | xMutant |
06 | SDL gene target drugs and drug sensitivity | TopicSem | ||
14 | miRNA analysis pipeline and report format | xMutant |
12 | Measuring intratumor heterogeneity by network entropy using RNA-seq data | J.Club |
17 | Classification and segmentation in convolutional neural network | xMutant | ||
29 | Synthetic dosage cancer survival analysis: Methylation and Under-expression | TopicSem |
01 | GeneScore calculation strategy | xMutant |
16 | Synthetic dosage cancer survival gene pairs | TopicSem |
15 | Mutual exclusive network and inference target from drug sensitivity | xMutant | ||
29 | ENCAPP: elastic-net-based prognosis prediction and biomarker discovery for human cancers | J.Club |
26 | Synthetic dosage cancer survival | TopicSem | ||
9 | WGCNA Network analysis of Microarray data | SysBiol |
04 | Pan-cancer Analysis for Disrupted Gene Network via Developmental Origins | TopicSem | ||
25 | Microarray analysis (Illumina), research results | SysBiol |
19 | Pan-cancer analysis of the extent and consequences of intratumor heterogeneity | J.Club | ||
22 | How to use MuTect, ExomeCNV and EXPANDS. | xMutant | ||
23 | intratumor heterogeneity analysis | TopicSem |
03 | Overexpression using normal expression in SDL analysis | xMutant | ||
23 | Synthetic Cancer Survival by Dosage | TopicSem |
07 | Current_progress_of_the_SDL_analysis | TopicSem |
21 | Synthetic dosage lethality in LUAD | xMutant |
22 | Synthetic Dosage Lethality in Lung Adenocarcinoma | TopicSem |
09 | Improved data analysis for the MinION nanopore sequencer | J.Club | ||
18 | RNAseq data Filtering and Normalization and SDL regression analysis | TopicSem |
15 | RNAseq Normalization and SDL regression analysis | TopicSem |
16 | What is overexpression in Synthetic dosage lethality | TopicSem |
26 | SG14 | Seminar |